| Drug Type Drug conjugates | 
| Synonyms- | 
| Target | 
| Action inhibitors, agonists | 
| Mechanism ACAN inhibitors(Aggrecan core protein inhibitors), IL15R agonists(Interleukin-15 receptors agonists), MAGEA1 inhibitors(Melanoma-associated antigen 1 inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseDiscovery | 
| First Approval Date- | 
| Regulation- | 

| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Melanoma | Discovery | United States  | - | 





